Previous close | 17.28 |
Open | 17.30 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 17.28 - 17.40 |
52-week range | 13.48 - 23.40 |
Volume | |
Avg. volume | 3,521 |
Market cap | 71.917B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 12.98 |
EPS (TTM) | 1.34 |
Earnings date | N/A |
Forward dividend & yield | 0.73 (4.22%) |
Ex-dividend date | 23 Feb 2023 |
1y target est | N/A |
The Equity Index 2022/23 produced by Lead 5050 ranked firms using official data on average salaries, bonuses, and pay.
GSK announces the FDA approval of daprodustat for the treatment of anemia due to chronic kidney disease (CKD) in adults on dialysis for at least four months.
Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas